Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase.
Sen YangXiaoshuai ZhangRobert Peter GaleXin DuChun-Yan ChenJian-Yu WengJian HuangFei LiYun ZengZhen XiaoJian-da HuLi-Jie YangZhuo-Gang LiuGuo-Hui LiXiu-Li SunWei YangRu FengYan-Qiu HanYu JingNa XuXiao-Li LiuZhen-Fang LiuXiao-Dong WangShi-Xin WuRong LiangYan-Li ZhangYun-Fan YangHuan-Ling ZhuLing PanLi MengYan-Hong ZhaoHai YiYi-Lan LiuWei-Hua ZhangYuan-Jun ZhengZe-Ping ZhouSu-Ning ChenHui-Ying QiuWei-Ming LiZhi-Lin JiaYan-Liang BaiLi-E LinBing-Cheng LiuChun-Shui LiuJian-Min LuoJun-Xia MengZhi-Qiang SunYan-Qing ZhangXiao-Jun HuangQian JiangPublished in: American journal of hematology (2023)
Keyphrases